Whole exome sequencing study of a Chinese concurrent cancer family

Cancer is one of the leading causes of mortality in China, and poses a threat to public health due to its increasing incidence and mortality rates. Concurrent cancer is defined as one or more organs in the same individual having ≥2 primary malignancies occurring simultaneously or successively; howev...

Ausführliche Beschreibung

Gespeichert in:
Bibliographische Detailangaben
Veröffentlicht in:Experimental and therapeutic medicine 2019-09, Vol.18 (3), p.2619-2627
Hauptverfasser: Yin, Yifa, Wu, Shouxin, Zhao, Xincheng, Zou, Liyong, Luo, Aihua, Deng, Fei, Min, Mengyun, Jiang, Lisha, Liu, Huimin, Wu, Xiangbai
Format: Artikel
Sprache:eng
Schlagworte:
Online-Zugang:Volltext
Tags: Tag hinzufügen
Keine Tags, Fügen Sie den ersten Tag hinzu!
container_end_page 2627
container_issue 3
container_start_page 2619
container_title Experimental and therapeutic medicine
container_volume 18
creator Yin, Yifa
Wu, Shouxin
Zhao, Xincheng
Zou, Liyong
Luo, Aihua
Deng, Fei
Min, Mengyun
Jiang, Lisha
Liu, Huimin
Wu, Xiangbai
description Cancer is one of the leading causes of mortality in China, and poses a threat to public health due to its increasing incidence and mortality rates. Concurrent cancer is defined as one or more organs in the same individual having ≥2 primary malignancies occurring simultaneously or successively; however, concurrent cases are rare and poorly studied. The present study recruited a Chinese family presenting multiple cases of concurrent cancer and performed whole exome sequencing in one unaffected and two affected individuals to identify the causative mutations. DNA was extracted from peripheral blood and tumor tissue samples. Following an exome capture and quality test, the qualified library was sequenced as 100 bp paired-end reads on an Ion Torrent platform. Clean data were obtained by filtering out the low-quality reads. Subsequently, bioinformatics analyses were performed using the clean data. After mapping and annotating in 1000 Genomes Project database, the existing SNP database and the Cancer Gene Census (CGC) database, it was revealed that the NADH:ubiquinone oxidoreductase core subunit S7 gene was a candidate gene with somatic mutations, and a subset of 16 genes were candidate genes with germline mutations. The findings of the present study may improve the understanding of the molecular pathogenesis of concurrent cancer.
doi_str_mv 10.3892/ol.2019.10573
format Article
fullrecord <record><control><sourceid>gale_pubme</sourceid><recordid>TN_cdi_pubmedcentral_primary_oai_pubmedcentral_nih_gov_6676670</recordid><sourceformat>XML</sourceformat><sourcesystem>PC</sourcesystem><galeid>A602105500</galeid><sourcerecordid>A602105500</sourcerecordid><originalsourceid>FETCH-LOGICAL-c536t-43f60a0924c6c0479eb514ce1290707f2a3586460240be01c925353c325e6dbe3</originalsourceid><addsrcrecordid>eNqNks9rHCEUx4fS0IQkx16LUCi9zEafo85cCunSXxDopaVHcd03OwZHU50p3f--bpNusqHQqqDo533fD19VPWd0wdsOLqJfAGXdglGh-JPqhKkOakZbeLo_q-a4Os_5mpYhJGtb-aw65qwRoBp5Ur39NkSPBH_GEUnG7zMG68KG5Gleb0nsiSHLwQXMSGwMdk4Jw0SsCRYT6c3o_PasOuqNz3h-t59WX9-_-7L8WF99_vBpeXlVW8HlVDe8l9TQDhorLW1UhyvBGosMOqqo6sFw0cpGUmjoCimzHQguuOUgUK5XyE-rN7e6N_NqxLUtgSTj9U1yo0lbHY3Thy_BDXoTf2gpVVm0CLy-E0ixJJonPbps0XsTMM5ZA7SMMQqyLejLR-h1nFMo6RWqE1wp4HBPbYxH7UIfi1-7E9WXknImOMC_KCh_J-guuMVfqDLXOLpSeuxduT-Q_U-Dew-vHhgMaPw05OjnycWQD8H6FrQp5pyw39eYUb3rOx293vWd_t13hX_x8GP29J8u478AMhHNAA</addsrcrecordid><sourcetype>Open Access Repository</sourcetype><iscdi>true</iscdi><recordtype>article</recordtype><pqid>2295377232</pqid></control><display><type>article</type><title>Whole exome sequencing study of a Chinese concurrent cancer family</title><source>Spandidos Publications Journals</source><source>Elektronische Zeitschriftenbibliothek - Frei zugängliche E-Journals</source><source>PubMed Central</source><creator>Yin, Yifa ; Wu, Shouxin ; Zhao, Xincheng ; Zou, Liyong ; Luo, Aihua ; Deng, Fei ; Min, Mengyun ; Jiang, Lisha ; Liu, Huimin ; Wu, Xiangbai</creator><creatorcontrib>Yin, Yifa ; Wu, Shouxin ; Zhao, Xincheng ; Zou, Liyong ; Luo, Aihua ; Deng, Fei ; Min, Mengyun ; Jiang, Lisha ; Liu, Huimin ; Wu, Xiangbai</creatorcontrib><description>Cancer is one of the leading causes of mortality in China, and poses a threat to public health due to its increasing incidence and mortality rates. Concurrent cancer is defined as one or more organs in the same individual having ≥2 primary malignancies occurring simultaneously or successively; however, concurrent cases are rare and poorly studied. The present study recruited a Chinese family presenting multiple cases of concurrent cancer and performed whole exome sequencing in one unaffected and two affected individuals to identify the causative mutations. DNA was extracted from peripheral blood and tumor tissue samples. Following an exome capture and quality test, the qualified library was sequenced as 100 bp paired-end reads on an Ion Torrent platform. Clean data were obtained by filtering out the low-quality reads. Subsequently, bioinformatics analyses were performed using the clean data. After mapping and annotating in 1000 Genomes Project database, the existing SNP database and the Cancer Gene Census (CGC) database, it was revealed that the NADH:ubiquinone oxidoreductase core subunit S7 gene was a candidate gene with somatic mutations, and a subset of 16 genes were candidate genes with germline mutations. The findings of the present study may improve the understanding of the molecular pathogenesis of concurrent cancer.</description><identifier>ISSN: 1792-1074</identifier><identifier>ISSN: 1792-0981</identifier><identifier>EISSN: 1792-1082</identifier><identifier>DOI: 10.3892/ol.2019.10573</identifier><identifier>PMID: 31452746</identifier><language>eng</language><publisher>Greece: Spandidos Publications</publisher><subject>Amino acids ; Cancer ; Cancer research ; Cell division ; China ; Computational biology ; Dehydrogenases ; Deoxyribonucleic acid ; DNA ; Family ; Gene mutation ; Genes ; Genetic testing ; Genomes ; Genomics ; Health aspects ; Mortality ; Mutation ; Oncology ; Patients ; Proteins ; Public health ; Single nucleotide polymorphisms ; Studies ; Tumors</subject><ispartof>Experimental and therapeutic medicine, 2019-09, Vol.18 (3), p.2619-2627</ispartof><rights>COPYRIGHT 2019 Spandidos Publications</rights><rights>Copyright Spandidos Publications UK Ltd. 2019</rights><rights>Copyright © 2019, Spandidos Publications 2019</rights><oa>free_for_read</oa><woscitedreferencessubscribed>false</woscitedreferencessubscribed><cites>FETCH-LOGICAL-c536t-43f60a0924c6c0479eb514ce1290707f2a3586460240be01c925353c325e6dbe3</cites></display><links><openurl>$$Topenurl_article</openurl><openurlfulltext>$$Topenurlfull_article</openurlfulltext><thumbnail>$$Tsyndetics_thumb_exl</thumbnail><linktopdf>$$Uhttps://www.ncbi.nlm.nih.gov/pmc/articles/PMC6676670/pdf/$$EPDF$$P50$$Gpubmedcentral$$H</linktopdf><linktohtml>$$Uhttps://www.ncbi.nlm.nih.gov/pmc/articles/PMC6676670/$$EHTML$$P50$$Gpubmedcentral$$H</linktohtml><link.rule.ids>230,314,727,780,784,885,27924,27925,53791,53793</link.rule.ids><backlink>$$Uhttps://www.ncbi.nlm.nih.gov/pubmed/31452746$$D View this record in MEDLINE/PubMed$$Hfree_for_read</backlink></links><search><creatorcontrib>Yin, Yifa</creatorcontrib><creatorcontrib>Wu, Shouxin</creatorcontrib><creatorcontrib>Zhao, Xincheng</creatorcontrib><creatorcontrib>Zou, Liyong</creatorcontrib><creatorcontrib>Luo, Aihua</creatorcontrib><creatorcontrib>Deng, Fei</creatorcontrib><creatorcontrib>Min, Mengyun</creatorcontrib><creatorcontrib>Jiang, Lisha</creatorcontrib><creatorcontrib>Liu, Huimin</creatorcontrib><creatorcontrib>Wu, Xiangbai</creatorcontrib><title>Whole exome sequencing study of a Chinese concurrent cancer family</title><title>Experimental and therapeutic medicine</title><addtitle>Oncol Lett</addtitle><description>Cancer is one of the leading causes of mortality in China, and poses a threat to public health due to its increasing incidence and mortality rates. Concurrent cancer is defined as one or more organs in the same individual having ≥2 primary malignancies occurring simultaneously or successively; however, concurrent cases are rare and poorly studied. The present study recruited a Chinese family presenting multiple cases of concurrent cancer and performed whole exome sequencing in one unaffected and two affected individuals to identify the causative mutations. DNA was extracted from peripheral blood and tumor tissue samples. Following an exome capture and quality test, the qualified library was sequenced as 100 bp paired-end reads on an Ion Torrent platform. Clean data were obtained by filtering out the low-quality reads. Subsequently, bioinformatics analyses were performed using the clean data. After mapping and annotating in 1000 Genomes Project database, the existing SNP database and the Cancer Gene Census (CGC) database, it was revealed that the NADH:ubiquinone oxidoreductase core subunit S7 gene was a candidate gene with somatic mutations, and a subset of 16 genes were candidate genes with germline mutations. The findings of the present study may improve the understanding of the molecular pathogenesis of concurrent cancer.</description><subject>Amino acids</subject><subject>Cancer</subject><subject>Cancer research</subject><subject>Cell division</subject><subject>China</subject><subject>Computational biology</subject><subject>Dehydrogenases</subject><subject>Deoxyribonucleic acid</subject><subject>DNA</subject><subject>Family</subject><subject>Gene mutation</subject><subject>Genes</subject><subject>Genetic testing</subject><subject>Genomes</subject><subject>Genomics</subject><subject>Health aspects</subject><subject>Mortality</subject><subject>Mutation</subject><subject>Oncology</subject><subject>Patients</subject><subject>Proteins</subject><subject>Public health</subject><subject>Single nucleotide polymorphisms</subject><subject>Studies</subject><subject>Tumors</subject><issn>1792-1074</issn><issn>1792-0981</issn><issn>1792-1082</issn><fulltext>true</fulltext><rsrctype>article</rsrctype><creationdate>2019</creationdate><recordtype>article</recordtype><sourceid>ABUWG</sourceid><sourceid>AFKRA</sourceid><sourceid>BENPR</sourceid><sourceid>CCPQU</sourceid><recordid>eNqNks9rHCEUx4fS0IQkx16LUCi9zEafo85cCunSXxDopaVHcd03OwZHU50p3f--bpNusqHQqqDo533fD19VPWd0wdsOLqJfAGXdglGh-JPqhKkOakZbeLo_q-a4Os_5mpYhJGtb-aw65qwRoBp5Ur39NkSPBH_GEUnG7zMG68KG5Gleb0nsiSHLwQXMSGwMdk4Jw0SsCRYT6c3o_PasOuqNz3h-t59WX9-_-7L8WF99_vBpeXlVW8HlVDe8l9TQDhorLW1UhyvBGosMOqqo6sFw0cpGUmjoCimzHQguuOUgUK5XyE-rN7e6N_NqxLUtgSTj9U1yo0lbHY3Thy_BDXoTf2gpVVm0CLy-E0ixJJonPbps0XsTMM5ZA7SMMQqyLejLR-h1nFMo6RWqE1wp4HBPbYxH7UIfi1-7E9WXknImOMC_KCh_J-guuMVfqDLXOLpSeuxduT-Q_U-Dew-vHhgMaPw05OjnycWQD8H6FrQp5pyw39eYUb3rOx293vWd_t13hX_x8GP29J8u478AMhHNAA</recordid><startdate>20190901</startdate><enddate>20190901</enddate><creator>Yin, Yifa</creator><creator>Wu, Shouxin</creator><creator>Zhao, Xincheng</creator><creator>Zou, Liyong</creator><creator>Luo, Aihua</creator><creator>Deng, Fei</creator><creator>Min, Mengyun</creator><creator>Jiang, Lisha</creator><creator>Liu, Huimin</creator><creator>Wu, Xiangbai</creator><general>Spandidos Publications</general><general>Spandidos Publications UK Ltd</general><general>D.A. Spandidos</general><scope>NPM</scope><scope>AAYXX</scope><scope>CITATION</scope><scope>3V.</scope><scope>7X7</scope><scope>7XB</scope><scope>8FI</scope><scope>8FJ</scope><scope>8FK</scope><scope>ABUWG</scope><scope>AFKRA</scope><scope>AN0</scope><scope>BENPR</scope><scope>CCPQU</scope><scope>FYUFA</scope><scope>GHDGH</scope><scope>K9.</scope><scope>M0S</scope><scope>PQEST</scope><scope>PQQKQ</scope><scope>PQUKI</scope><scope>PRINS</scope><scope>7X8</scope><scope>5PM</scope></search><sort><creationdate>20190901</creationdate><title>Whole exome sequencing study of a Chinese concurrent cancer family</title><author>Yin, Yifa ; Wu, Shouxin ; Zhao, Xincheng ; Zou, Liyong ; Luo, Aihua ; Deng, Fei ; Min, Mengyun ; Jiang, Lisha ; Liu, Huimin ; Wu, Xiangbai</author></sort><facets><frbrtype>5</frbrtype><frbrgroupid>cdi_FETCH-LOGICAL-c536t-43f60a0924c6c0479eb514ce1290707f2a3586460240be01c925353c325e6dbe3</frbrgroupid><rsrctype>articles</rsrctype><prefilter>articles</prefilter><language>eng</language><creationdate>2019</creationdate><topic>Amino acids</topic><topic>Cancer</topic><topic>Cancer research</topic><topic>Cell division</topic><topic>China</topic><topic>Computational biology</topic><topic>Dehydrogenases</topic><topic>Deoxyribonucleic acid</topic><topic>DNA</topic><topic>Family</topic><topic>Gene mutation</topic><topic>Genes</topic><topic>Genetic testing</topic><topic>Genomes</topic><topic>Genomics</topic><topic>Health aspects</topic><topic>Mortality</topic><topic>Mutation</topic><topic>Oncology</topic><topic>Patients</topic><topic>Proteins</topic><topic>Public health</topic><topic>Single nucleotide polymorphisms</topic><topic>Studies</topic><topic>Tumors</topic><toplevel>online_resources</toplevel><creatorcontrib>Yin, Yifa</creatorcontrib><creatorcontrib>Wu, Shouxin</creatorcontrib><creatorcontrib>Zhao, Xincheng</creatorcontrib><creatorcontrib>Zou, Liyong</creatorcontrib><creatorcontrib>Luo, Aihua</creatorcontrib><creatorcontrib>Deng, Fei</creatorcontrib><creatorcontrib>Min, Mengyun</creatorcontrib><creatorcontrib>Jiang, Lisha</creatorcontrib><creatorcontrib>Liu, Huimin</creatorcontrib><creatorcontrib>Wu, Xiangbai</creatorcontrib><collection>PubMed</collection><collection>CrossRef</collection><collection>ProQuest Central (Corporate)</collection><collection>Health &amp; Medical Collection</collection><collection>ProQuest Central (purchase pre-March 2016)</collection><collection>Hospital Premium Collection</collection><collection>Hospital Premium Collection (Alumni Edition)</collection><collection>ProQuest Central (Alumni) (purchase pre-March 2016)</collection><collection>ProQuest Central (Alumni Edition)</collection><collection>ProQuest Central UK/Ireland</collection><collection>British Nursing Database</collection><collection>ProQuest Central</collection><collection>ProQuest One Community College</collection><collection>Health Research Premium Collection</collection><collection>Health Research Premium Collection (Alumni)</collection><collection>ProQuest Health &amp; Medical Complete (Alumni)</collection><collection>Health &amp; Medical Collection (Alumni Edition)</collection><collection>ProQuest One Academic Eastern Edition (DO NOT USE)</collection><collection>ProQuest One Academic</collection><collection>ProQuest One Academic UKI Edition</collection><collection>ProQuest Central China</collection><collection>MEDLINE - Academic</collection><collection>PubMed Central (Full Participant titles)</collection><jtitle>Experimental and therapeutic medicine</jtitle></facets><delivery><delcategory>Remote Search Resource</delcategory><fulltext>fulltext</fulltext></delivery><addata><au>Yin, Yifa</au><au>Wu, Shouxin</au><au>Zhao, Xincheng</au><au>Zou, Liyong</au><au>Luo, Aihua</au><au>Deng, Fei</au><au>Min, Mengyun</au><au>Jiang, Lisha</au><au>Liu, Huimin</au><au>Wu, Xiangbai</au><format>journal</format><genre>article</genre><ristype>JOUR</ristype><atitle>Whole exome sequencing study of a Chinese concurrent cancer family</atitle><jtitle>Experimental and therapeutic medicine</jtitle><addtitle>Oncol Lett</addtitle><date>2019-09-01</date><risdate>2019</risdate><volume>18</volume><issue>3</issue><spage>2619</spage><epage>2627</epage><pages>2619-2627</pages><issn>1792-1074</issn><issn>1792-0981</issn><eissn>1792-1082</eissn><abstract>Cancer is one of the leading causes of mortality in China, and poses a threat to public health due to its increasing incidence and mortality rates. Concurrent cancer is defined as one or more organs in the same individual having ≥2 primary malignancies occurring simultaneously or successively; however, concurrent cases are rare and poorly studied. The present study recruited a Chinese family presenting multiple cases of concurrent cancer and performed whole exome sequencing in one unaffected and two affected individuals to identify the causative mutations. DNA was extracted from peripheral blood and tumor tissue samples. Following an exome capture and quality test, the qualified library was sequenced as 100 bp paired-end reads on an Ion Torrent platform. Clean data were obtained by filtering out the low-quality reads. Subsequently, bioinformatics analyses were performed using the clean data. After mapping and annotating in 1000 Genomes Project database, the existing SNP database and the Cancer Gene Census (CGC) database, it was revealed that the NADH:ubiquinone oxidoreductase core subunit S7 gene was a candidate gene with somatic mutations, and a subset of 16 genes were candidate genes with germline mutations. The findings of the present study may improve the understanding of the molecular pathogenesis of concurrent cancer.</abstract><cop>Greece</cop><pub>Spandidos Publications</pub><pmid>31452746</pmid><doi>10.3892/ol.2019.10573</doi><tpages>9</tpages><oa>free_for_read</oa></addata></record>
fulltext fulltext
identifier ISSN: 1792-1074
ispartof Experimental and therapeutic medicine, 2019-09, Vol.18 (3), p.2619-2627
issn 1792-1074
1792-0981
1792-1082
language eng
recordid cdi_pubmedcentral_primary_oai_pubmedcentral_nih_gov_6676670
source Spandidos Publications Journals; Elektronische Zeitschriftenbibliothek - Frei zugängliche E-Journals; PubMed Central
subjects Amino acids
Cancer
Cancer research
Cell division
China
Computational biology
Dehydrogenases
Deoxyribonucleic acid
DNA
Family
Gene mutation
Genes
Genetic testing
Genomes
Genomics
Health aspects
Mortality
Mutation
Oncology
Patients
Proteins
Public health
Single nucleotide polymorphisms
Studies
Tumors
title Whole exome sequencing study of a Chinese concurrent cancer family
url https://sfx.bib-bvb.de/sfx_tum?ctx_ver=Z39.88-2004&ctx_enc=info:ofi/enc:UTF-8&ctx_tim=2025-01-05T16%3A21%3A10IST&url_ver=Z39.88-2004&url_ctx_fmt=infofi/fmt:kev:mtx:ctx&rfr_id=info:sid/primo.exlibrisgroup.com:primo3-Article-gale_pubme&rft_val_fmt=info:ofi/fmt:kev:mtx:journal&rft.genre=article&rft.atitle=Whole%20exome%20sequencing%20study%20of%20a%20Chinese%20concurrent%20cancer%20family&rft.jtitle=Experimental%20and%20therapeutic%20medicine&rft.au=Yin,%20Yifa&rft.date=2019-09-01&rft.volume=18&rft.issue=3&rft.spage=2619&rft.epage=2627&rft.pages=2619-2627&rft.issn=1792-1074&rft.eissn=1792-1082&rft_id=info:doi/10.3892/ol.2019.10573&rft_dat=%3Cgale_pubme%3EA602105500%3C/gale_pubme%3E%3Curl%3E%3C/url%3E&disable_directlink=true&sfx.directlink=off&sfx.report_link=0&rft_id=info:oai/&rft_pqid=2295377232&rft_id=info:pmid/31452746&rft_galeid=A602105500&rfr_iscdi=true